GLP1R and diabetes mellitus: Although some of the studies have indicated GLP-1 agonists could reduce infarct size and improve cardiac function after myocardial ischemia in rodents with or without diabetes, the relative effects of these agents on cardiac remodeling in nondiabetic mice have not been studied.